Three things to know:
1. The clinical trial, launched in November, seeks to identify the most effective Ebola treatment of four experimental therapies: Remdesivir, mAb114, REGN-EB3 and ZMapp.
2. The trial will now involve Ebola patients in treatment centers in Katwa and Butembo — current hot spots of Congo’s Ebola outbreak.
3. As of Feb. 11, the World Health Organization reported 819 confirmed and probable infections linked to the outbreak, which started in August.
More articles on clinical leadership & infection control:
Why combining nurse perspective with scientific approach improves care
Health experts urge Facebook to crack down on anti-vaccine groups
Former CDC leader on bird flu threat: ‘We don’t know how the story’s going to end’
